NEW YORK (GenomeWeb News) – The Van Andel Institute and Spectrum Health have started a molecular technologies lab that will study genomics and proteomics for application in cancer, heart disease, mental illness, and other diseases, Spectrum Health said today.
 
Spectrum, a non-profit group that operates seven hospitals in Western Michigan, said the Center for Molecular Medicine, located in Grand Rapids, has $6 million in funding.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A small study finds differences between three genomic prostate cancer tests, Medscape reports.

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Jun
19
Sponsored by
Advanced Cell Diagnostics

This webinar will provide evidence for the use of RNA in situ hybridization (RNA ISH) as a replacement for immunohistochemistry (IHC) in cancer research and diagnostic applications.

Jun
21
Sponsored by
Roche

This webinar will provide a detailed look at how a genomics lab implemented next-generation sequencing (NGS) liquid biopsy assays into its in-house clinical research program.